2019
DOI: 10.1016/j.jchromb.2019.121803
|View full text |Cite
|
Sign up to set email alerts
|

Determination of pioglitazone, its metabolite and alogliptin in human plasma by a novel LC-MS/MS method; application to a pharmacokinetic study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…The calibration plot between PG-HCl concentration (in mg L À1 ) taken as abscissa and CL intensity peak height (in millivolts) taken as ordinate was linear over the range 0.001-5. FI-Spec 0.5-10 0.26 NR <1.09 [10] FI-Spec 0.5-15 0.14 0.46 <1.1 [11] Spec-FL 0.005-1.3 0.00161 0.00487 0.60 [12] Spec-FL 0.02-0.06 0.0102 0.0309 NR [13] Voltammetry 0.0039-39.29 0.00317 0.00963 <2.0 [14] Voltammetry HPLC-UV 0.25-10 0.08 0.25 2.7 [19] HPLC-UV 3-15 0.047 0.1427 <2.0 [23] LC-MS/MS 0.01-0.05 0.001 NR 18.8 [24] LC-MS/MS 0.01-3 0.01 NR 2.1-3.8 [25] HPTLC 60-600 ng band À1 8.51 ng band À1 25.77 ng band À1 0.51 [26] RP-TLC 40-240 6.0 20 0.66-1.09 [27] FI-CL 0.05-3.0 0.01 0.05 <2.0 [44] FI-CL 0.001-5.0 2.2 Â 10 À4 6.7 Â 10 À4 1.0-3.3 This method Spec, spectrophotometry: NR, not reported; FI-Spec, flow injection-spectrophotometry; Spec-FL, spectrofluorometry; CE, capillary electrophoresis; MEKC, miceller electro-kinetic chromatography; HPLC-UV, high-performance liquid chromatography-ultraviolet; LC-MS/MS, liquid chromatography-tandem mass spectrometry; HPTLC, high-performance thin layer chromatography; RP-TLC, reversed phase-thin layer chromatography; FI-CL, flow injectionchemiluminescence; LOD, limit of detection; LOQ, limit of quantification; RSD, relative standard deviation.…”
Section: Calibration Datamentioning
confidence: 99%
See 2 more Smart Citations
“…The calibration plot between PG-HCl concentration (in mg L À1 ) taken as abscissa and CL intensity peak height (in millivolts) taken as ordinate was linear over the range 0.001-5. FI-Spec 0.5-10 0.26 NR <1.09 [10] FI-Spec 0.5-15 0.14 0.46 <1.1 [11] Spec-FL 0.005-1.3 0.00161 0.00487 0.60 [12] Spec-FL 0.02-0.06 0.0102 0.0309 NR [13] Voltammetry 0.0039-39.29 0.00317 0.00963 <2.0 [14] Voltammetry HPLC-UV 0.25-10 0.08 0.25 2.7 [19] HPLC-UV 3-15 0.047 0.1427 <2.0 [23] LC-MS/MS 0.01-0.05 0.001 NR 18.8 [24] LC-MS/MS 0.01-3 0.01 NR 2.1-3.8 [25] HPTLC 60-600 ng band À1 8.51 ng band À1 25.77 ng band À1 0.51 [26] RP-TLC 40-240 6.0 20 0.66-1.09 [27] FI-CL 0.05-3.0 0.01 0.05 <2.0 [44] FI-CL 0.001-5.0 2.2 Â 10 À4 6.7 Â 10 À4 1.0-3.3 This method Spec, spectrophotometry: NR, not reported; FI-Spec, flow injection-spectrophotometry; Spec-FL, spectrofluorometry; CE, capillary electrophoresis; MEKC, miceller electro-kinetic chromatography; HPLC-UV, high-performance liquid chromatography-ultraviolet; LC-MS/MS, liquid chromatography-tandem mass spectrometry; HPTLC, high-performance thin layer chromatography; RP-TLC, reversed phase-thin layer chromatography; FI-CL, flow injectionchemiluminescence; LOD, limit of detection; LOQ, limit of quantification; RSD, relative standard deviation.…”
Section: Calibration Datamentioning
confidence: 99%
“…Table 2 summarizes calibration data of previously published procedures [8,[10][11][12][13][14][15][16][17][18][19][23][24][25][26][27]44] for the quantification of PG-HCl in medicinal samples and compares them with the present FI approach. The results were comparable to or even better than most results obtained from the reported methods.…”
Section: Calibration Datamentioning
confidence: 99%
See 1 more Smart Citation
“…The literature reveals that various separation methods were used for the individual determination of MET [ 14 ] and with other diabetic drugs [ 15 , 16 , 17 ]. In addition, several chromatographic methods were reported for the determination of PIO, either alone [ 18 , 19 ] or with its main metabolites [ 20 , 21 ], besides in combination with other drugs [ 22 , 23 , 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…A review of the existing literature focusing on the quantitative analysis of TGT and PGZ indicated that efforts have been directed toward devising analytical methods for these individual drugs, as well as in combination with other medications. These efforts have resulted in developing various methods including UV spectroscopy [3,[12][13][14][15], HPLC [2,3,7,[16][17][18][19][20][21][22][23], high-performance thin-layer chromatography (HPTLC) [15,[24][25][26][27][28][29], and LC-MS [23,[30][31][32][33][34][35][36]. Among the various methods that have been reported, the work by Gheewala et al in 2017 provided a comprehensive account of simultaneously determining TGT and PGZ within a synthetic mixture using both UV spectroscopy and HPLC.…”
Section: Introductionmentioning
confidence: 99%